# What Pinealon Research Measured in a Mouse Model of Amyloid Disease

- Article ID: research-299
- Product: Pinealon (pinealon-716)
- Canonical page: https://heritagebiolabs.com/research-library/articles/299-what-pinealon-research-measured-in-a-mouse-model-of-amyloid-disease
- Product collection: https://heritagebiolabs.com/research-library/products/pinealon
- Product page: https://heritagebiolabs.com/product/pinealon-716
- Reading focus: Methods & identity (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2021

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short chains of amino acids connected by peptide bonds. Some are investigated for effects on structures that help nerve cells communicate. Pinealon, also known as EDR, is a synthetic tripeptide. A 2021 study included EDR and a different tripeptide called KED in research on a mouse model used to examine selected features of Alzheimer's disease. This older experiment supplies direct evidence on the model and the structural measurement described here. [1]

The researchers looked at dendritic spines, small protrusions on a nerve cell's branches that are associated with many of its connections. Loss of these structures is one way to study changes related to amyloid in a model. The paper reported that EDR and KED were associated with less loss of spines in the model conditions examined. Findings about one tripeptide should still be kept separate from results reported for the other. The two names represent different chains. [1]

A structural measurement can tell investigators whether a feature was more or less common in a sample. It does not tell them everything about the strength or timing of communication between cells. It also does not establish that an animal performs better on a task unless behavior is measured in an appropriate comparison. A mouse model can reproduce aspects of amyloid biology without representing the full course of human dementia. [1]

The study provides a reason to ask whether the observed structures correspond to functional differences. It does not show that Pinealon treats Alzheimer's disease, restores lost memory or alters the course of illness in people. The strongest claim stays with the measured feature in the specific model. [1]

## Sources

1. Khavinson V et al. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (2021-05-27). <https://pubmed.ncbi.nlm.nih.gov/34071923/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 060 - PEG-MGF and Pinealon.docx; article 299; content SHA-256 a318338e1caf4b26166d573e6c28841ba660f98c31450103fc75011f774f5be4.
